142172-51-8 2-(4-Bromobutyl)benzo[d][1,3,2]dioxaborole
BD231623142172-51-895+%
¥1207.05g
13826-27-2 2,2'-Bibenzo[d][1,3,2]dioxaborole
BD1373713826-27-298% HPLC
¥176.025g
406191-34-2 BcATc Inhibitor 2
BD01145948406191-34-299+%
1800024-45-6 2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile
BD013574331800024-45-698%
¥4006.01g
N/A (4-(5-(2-Aminoethyl)benzo[d][1,3,2]dioxaborol-2-yl)phenyl)methanol
BD01384000N/A
N/A 2-(2-(4-(Hydroxymethyl)phenyl)benzo[d][1,3,2]dioxaborol-5-yl)acetic acid
BD01414723N/A
1875078-61-7 BCAT-IN-1
BD014638521875078-61-798%
155956-31-3 2-(1-Bromoethyl)benzo[d][1,3,2]dioxaborole
BD01581249155956-31-395%
1415683-79-2 Sodium 4-methyl-5-oxohexanoate
BD016280461415683-79-298%
2771756-82-0 BAY-771
BD018801732771756-82-098%
2639638-66-5 3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione-iso-1
BD021943912639638-66-595%
2639638-67-6 3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione-iso-2
BD021856022639638-67-695%
1